Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nkem O. Azu
Observed name:
Nkem Azu
Institution:
BASF (United States)
Observed institutions:
Mayo Clinic,
BASF (United States),
Mayo Clinic in Florida
ORCID:
0000-0002-0147-1280
Observed ORCID:
0000-0002-0147-1280
OpenAlex ID:
A5015346453
Transcriptomic analysis to identify genes associated with selective hippocampal vulnerability in Alzheimer’s disease
2021
·
Angela M. Crist
, Kelly M. Hinkle
, et al.
·
Nature Communications
·
89
PDF
Guggulsterone for Chemoprevention of Cancer
2015
·
Shishir Shishodia
, Nkem Azu
, et al.
·
Current Pharmaceutical Design
·
38
Mixed bacterial responses to dust exposure in an A549 eukaryotic co-culture
2018
·
Mariam Bado
, Djene Keita
, et al.
·
Applied Microbiology and Biotechnology
·
7
Leveraging selective hippocampal vulnerability among Alzheimer’s disease subtypes reveals a novel tau binding partner SERPINA5
2020
·
Angela M. Crist
, Kelly M. Hinkle
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
3
PDF
4,4′--Diphenylmethane diisocyanate (MDI)
2023
·
Nkem O. Azu
·
Elsevier eBooks
Tetrahydrofuran
2023
·
Nkem O. Azu
·
Elsevier eBooks
Toluene diisocyanate
2022
·
Nkem Azu
, Anne Chappelle
·
Elsevier eBooks
Investigating gene expression changes underlying selective hippocampal vulnerability in Alzheimer’s disease using a translational neuropathology approach
2020
·
Angela M. Crist
, Kelly M. Hinkle
, et al.
·
Alzheimer s & Dementia
Show more works
View as search
Works count:
8
Citation count:
137
H-index:
3
I10-index:
2
Year
Topic
Type
